Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

NCT03799835 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

517

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: BCG
DRUG: Atezolizumab

Sponsor

UNICANCER

Collaborators

[object Object]